Eric Weisblum - Nov 22, 2023 Form 4 Insider Report for Silo Pharma, Inc. (SILO)

Role: CEO and President, Director
Signature: /s/ Eric Weisblum
Stock symbol: SILO
Transactions as of: Nov 22, 2023
Transactions value $: $1,117
Form type: 4
Date filed: 11/27/2023, 05:13 PM
Previous filing: Nov 22, 2023
Next filing: Nov 30, 2023

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	SILO	Common Stock	Purchase	$672	+400	+0.24%	$1.68	165K	Nov 22, 2023	Direct	F1
transaction	SILO	Common Stock	Purchase	$445	+250	+0.15%	$1.78	165K	Nov 27, 2023	Direct

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.64 to $1.70. The reporting person undertakes to provide Silo Pharma, Inc., any security holder of Silo Pharma, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

Content

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.64 to $1.70. The reporting person undertakes to provide Silo Pharma, Inc., any security holder of Silo Pharma, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.